Recombinant monoclonal antibody specially binds to prothrombin. This human anti-prothrombin antibody (P13) can be widely used in the diagnosis of antiphospholipid syndrome patients.
Figure 1 Immunohistochemical studies of DCP in human HCC.
Serum DCP levels correlated with staining intensity of DCP.
Murata, K., Suzuki, H., Okano, H., Oyamada, T., Yasuda, Y., & Sakamoto, A. (2009). Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-γ-carboxy prothrombin production in hepatocellular carcinoma. International journal of oncology, 35(5), 1005-1014.
Figure 2 Immunofluorescent studies of DCP production.
DCP production in both cells (paired t-test) without any inhibitory effects of vitamin K2 (100 nM). Values are means ± SEM.
Murata, K., Suzuki, H., Okano, H., Oyamada, T., Yasuda, Y., & Sakamoto, A. (2009). Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-γ-carboxy prothrombin production in hepatocellular carcinoma. International journal of oncology, 35(5), 1005-1014.
Figure 3 DCP production in cells with reduced E-cadherin expression.
DCP production (red) was observed clearly
in TPA-treated cells along with reduced E-cadherin expression.
Murata, K., Suzuki, H., Okano, H., Oyamada, T., Yasuda, Y., & Sakamoto, A. (2009). Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-γ-carboxy prothrombin production in hepatocellular carcinoma. International journal of oncology, 35(5), 1005-1014.
Figure 4 TPA induced DCP production in a dose-dependent manner in HepG2.
TGF-β1 also induced DCP production in a dose-dependent manner in HepG2.
Murata, K., Suzuki, H., Okano, H., Oyamada, T., Yasuda, Y., & Sakamoto, A. (2009). Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-γ-carboxy prothrombin production in hepatocellular carcinoma. International journal of oncology, 35(5), 1005-1014.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0441MZ | Chicken Anti-Prothrombin Polyclonal IgY | WB | Chicken antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-AP223-YC | Recombinant Llama Anti-Prothrombin Single Domain Antibody (HPAB-AP223-YC) | ELISA, FuncS | |
HPAB-AP224-YC | Recombinant Llama Anti-Prothrombin Single Domain Antibody (HPAB-AP224-YC) | ELISA, FuncS | |
HPAB-AP225-YC | Recombinant Llama Anti-Prothrombin Single Domain Antibody (HPAB-AP225-YC) | ELISA, FuncS | |
HPAB-AP226-YC | Recombinant Llama Anti-Prothrombin Single Domain Antibody (HPAB-AP226-YC) | ELISA, FuncS |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0343JF-F(E) | Human Anti-Prothrombin Recombinant Antibody (clone P13); Fab Fragment | ELISA, FuncS | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0343JF-S(P) | Human Anti-Prothrombin Recombinant Antibody (clone P13); scFv Fragment | ELISA, FuncS | Human scFv |
There are currently no Customer reviews or questions for FAMAB-0343JF. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.